← back to search

Yu‐Pei Liao

California NanoSystems Institute · US
Area of research
Materials Chemistry · Biomedical Engineering
Research interest
Research interests include Nanoparticles: synthesis and applications, Graphene and Nanomaterials Applications, Cancer Immunotherapy and Biomarkers, and Immunotherapy and Immune Responses.
h-index
44
citations
7,660
works
96
NIH funding
primary concept
email

Recent publications

Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNA
ACS Nano 2025cited by 22position: middledoi
Use of a Liver-Targeting Immune-Tolerogenic mRNA Lipid Nanoparticle Platform to Treat Peanut-Induced Anaphylaxis by Single- and Multiple-Epitope Nucleotide Sequence Delivery
ACS Nano 2023cited by 94position: middledoi
Reprogramming the pancreatic cancer stroma and immune landscape by a silicasome nanocarrier delivering nintedanib, a protein tyrosine kinase inhibitor
Nano Today 2023cited by 13position: middledoi
Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs
ACS Nano 2022cited by 67position: middledoi
Nanocarrier Co-formulation for Delivery of a TLR7 Agonist plus an Immunogenic Cell Death Stimulus Triggers Effective Pancreatic Cancer Chemo-immunotherapy
ACS Nano 2022cited by 65position: middledoi
Combination Chemo‐Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti‐PD‐1
Advanced Science 2021cited by 132position: middledoi
Development of Facile and Versatile Platinum Drug Delivering Silicasome Nanocarriers for Efficient Pancreatic Cancer Chemo‐Immunotherapy
Small 2021cited by 72position: middledoi
Nanocellulose Length Determines the Differential Cytotoxic Effects and Inflammatory Responses in Macrophages and Hepatocytes
Small 2021cited by 63position: middledoi
Use of a liver-targeting nanoparticle platform to intervene in peanut-induced anaphylaxis through delivery of an Ara h2 T-cell epitope
Nano Today 2021cited by 30position: middledoi
Liposomal Delivery of Mitoxantrone and a Cholesteryl Indoximod Prodrug Provides Effective Chemo-immunotherapy in Multiple Solid Tumors
ACS Nano 2020cited by 166position: middledoi
Antigen- and Epitope-Delivering Nanoparticles Targeting Liver Induce Comparable Immunotolerance in Allergic Airway Disease and Anaphylaxis as Nanoparticle-Delivering Pharmaceuticals
ACS Nano 2020cited by 89position: middledoi
Lateral size of graphene oxide determines differential cellular uptake and cell death pathways in Kupffer cells, LSECs, and hepatocytes
Nano Today 2020cited by 84position: middledoi
Use of ratiometrically designed nanocarrier targeting CDK4/6 and autophagy pathways for effective pancreatic cancer treatment
Nature Communications 2020cited by 68position: middledoi
Mechanistic Differences in Cell Death Responses to Metal‐Based Engineered Nanomaterials in Kupffer Cells and Hepatocytes
Small 2020cited by 66position: middledoi
Use of Polymeric Nanoparticle Platform Targeting the Liver To Induce Treg-Mediated Antigen-Specific Immune Tolerance in a Pulmonary Allergen Sensitization Model
ACS Nano 2019cited by 119position: middledoi
The Crystallinity and Aspect Ratio of Cellulose Nanomaterials Determine Their Pro‐Inflammatory and Immune Adjuvant Effects In Vitro and In Vivo
Small 2019cited by 89position: middledoi
Surface Oxidation of Graphene Oxide Determines Membrane Damage, Lipid Peroxidation, and Cytotoxicity in Macrophages in a Pulmonary Toxicity Model
ACS Nano 2018cited by 278position: middledoi
Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway
ACS Nano 2018cited by 226position: middledoi
Toxicological Profiling of Metal Oxide Nanoparticles in Liver Context Reveals Pyroptosis in Kupffer Cells and Macrophages <i>versus</i> Apoptosis in Hepatocytes
ACS Nano 2018cited by 181position: middledoi
Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer
ACS Nano 2018cited by 126position: middledoi
Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
Nature Communications 2017cited by 437position: middledoi
Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer
Journal of Clinical Investigation 2017cited by 220position: middledoi
Reduction of pulmonary toxicity of metal oxide nanoparticles by phosphonate-based surface passivation
Particle and Fibre Toxicology 2017cited by 79position: middledoi
Enhanced Immune Adjuvant Activity of Aluminum Oxyhydroxide Nanorods through Cationic Surface Functionalization
ACS Applied Materials & Interfaces 2017cited by 71position: middledoi
Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic Cancer
ACS Nano 2016cited by 262position: middledoi
NADPH Oxidase-Dependent NLRP3 Inflammasome Activation and its Important Role in Lung Fibrosis by Multiwalled Carbon Nanotubes
Small 2015cited by 168position: middledoi
Enhancing the Imaging and Biosafety of Upconversion Nanoparticles through Phosphonate Coating
ACS Nano 2015cited by 150position: middledoi
Differences in the Toxicological Potential of 2D versus Aggregated Molybdenum Disulfide in the Lung
Small 2015cited by 127position: middledoi
Use of a Pro-Fibrogenic Mechanism-Based Predictive Toxicological Approach for Tiered Testing and Decision Analysis of Carbonaceous Nanomaterials
ACS Nano 2015cited by 119position: middledoi
Surface Interactions with Compartmentalized Cellular Phosphates Explain Rare Earth Oxide Nanoparticle Hazard and Provide Opportunities for Safer Design
ACS Nano 2014cited by 249position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

André E. Nel · California NanoSystems Institute30 papers (2012–2025)Chong Hyun Chang · Hainan University29 papers (2013–2023)Tian Xia · Berkeley College23 papers (2012–2023)Huan Meng · Jiangsu University18 papers (2012–2021)Xiangsheng Liu · Zhejiang Cancer Hospital17 papers (2016–2022)Jinhong Jiang · Southwest Petroleum University14 papers (2017–2021)Bingbing Sun · Sun Yat-sen University13 papers (2012–2018)Zhaoxia Ji · Anyang Tumor Hospital13 papers (2012–2018)Ruibin Li · Hebei Medical University11 papers (2012–2018)Xiang Wang · Shanxi Agricultural University10 papers (2019–2025)Qi Liu · Beihang University9 papers (2019–2021)Haiyuan Zhang · Harbin Institute of Technology7 papers (2012–2015)Kuo‐Ching Mei · University of North Carolina at Chapel Hill7 papers (2019–2022)Ying Ji · Harbin Normal University7 papers (2018–2021)Sijie Lin · Tongji University6 papers (2012–2015)Jiulong Li · National Center for Nanoscience and Technology5 papers (2020–2021)Mark C. Hersam · Northwestern University5 papers (2012–2020)Jianqin Lu · University of Arizona5 papers (2017–2019)Xiang Wang · City University of Hong Kong5 papers (2013–2017)Lijia Luo · California NanoSystems Institute4 papers (2022–2025)